Effect of Depression, Lifestyle on Cognitive Function in PLWHIV
Compared with patients without HIV, the poorer cognitive performances of PLWHIV were partly mediated by a higher prevalence of depressive symptoms.
HIV/AIDS
CDC: New HIV Transmission Often From Those Unaware of Infection
Most new HIV transmissions are from people who do not know they have HIV infection.
INF Treatment Lowers Risk for Diabetes and Mortality in HIV/HCV Coinfection
Sustained virologic response to the HCV in patients with HCV and HIV coinfection is associated with a lowered risk of diabetes and mortality.
Lactoferrin Ineffective for Patients with HIV Receiving ART
Recombinant human-lactoferrin treatment in PLWHIV receiving ART was not associated with significant improvements in inflammation or immune activation.
HIV Risk and Testing Behaviors in Pregnant Women
HIV during the perinatal period in the US have declined over recent decades, but its prevalence rates in female adults and adolescents continues to rise.
One-Month Regimen Noninferior for Preventing HIV-Related TB
One-month rifapentine, isoniazid noninferior to nine months of isoniazid alone.
Elevated BNP in HIV Associated With Adverse CV Events, Mortality
Increased levels of B-type natriuretic peptide are independently associated with cardiovascular events and mortality in people with HIV.
Long-Acting Regimen Noninferior to Daily ART for HIV-1
Monthly long-acting cabotegravir and rilpivirine noninferior in two randomized controlled trials.
Long-Acting Injectable HIV Regimen Effective in Maintaining Viral Suppression
ViiV Healthcare announced positive 48-week data from the phase 3 studies evaluating a long-acting injectable formulation of cabotegravir + rilpivirine in patients with HIV.
Quantitative HIV Antibodies Useful for Viral Suppression Screening in Children
Quantitative HIV antibody levels may be useful for screening for viral suppression or residual, cell-associated HIV DNA levels in children on ART.
Next post in HIV/AIDS
